Evergraf 0.5 mg Tablet
$17.79
$12.59
Evergraf 0.5 mg Tablet is a targeted anticancer therapy designed to combat several advanced malignancies, including cancers of the pancreas, stomach, intestines, and lungs that are no longer amenable to surgical intervention. This medication is particularly effective for postmenopausal women suffering from advanced hormone receptor-positive and HER2-negative breast cancer, providing a vital treatment option in challenging cases. Additionally, Evergraf is indicated for adult patients with advanced renal cell carcinoma who have experienced disease progression following treatment with sunitinib or sorafenib. The active ingredient in Evergraf works by inhibiting specific pathways that cancer cells rely on for growth and survival, thus slowing down the progression of the disease. It is essential to note potential side effects and interactions; patients should discuss their medical history and current medications with their healthcare provider before starting Evergraf. Regular monitoring is recommended to manage any adverse effects effectively. With its unique mechanism of action, Evergraf offers hope for those facing difficult-to-treat cancers, making it an important option in the realm of oncology.
Quantity
Active Pharmaceutical Ingredient
Uses
• Evergraf 0.5 mg tablet is primarily indicated for the treatment of postmenopausal women suffering from advanced hormone receptor-positive, HER2-negative breast cancer. In this context, the medication is often used in conjunction with exemestane after previous treatments with letrozole or anastrozole have proven ineffective. This targeted approach aims to slow disease progression and manage symptoms effectively. The use of Evergraf 0.5 mg tablet can be vital for maintaining quality of life during treatment.
• The administration of Evergraf 0.5 mg tablet can help address specific symptoms associated with advanced breast cancer. Patients may experience changes in breast appearance, such as size or shape alterations, which can significantly affect emotional well-being. By effectively targeting hormone receptors, Evergraf 0.5 mg tablet aids in managing these physical changes. This support is crucial for enhancing the overall treatment experience for patients.
• In the management of advanced hormone receptor-positive breast cancer, Evergraf 0.5 mg tablet plays a key role in prolonging the effectiveness of treatment regimens. It is particularly beneficial for those who have experienced a lack of response to previous therapies. By integrating Evergraf 0.5 mg tablet into their treatment plan, healthcare providers can offer patients an additional strategy to combat the disease. This can lead to improved outcomes and extended periods of stability in disease management.
• Evergraf 0.5 mg tablet is commonly prescribed to help patients cope with the challenges of advanced breast cancer. It is specifically designed to work alongside other medications, enhancing their effectiveness and providing a more comprehensive treatment approach. This combination therapy can significantly impact patients' treatment journeys, making Evergraf 0.5 mg tablet an essential component in managing advanced hormone receptor-positive breast cancer. Through its use, patients may experience better control over their symptoms and overall health.
Benefits
Evergraf 0.5 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Evergraf 0.5 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Evergraf 0.5 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
Evergraf 0.5 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Evergraf 0.5 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Evergraf 0.5 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Evergraf 0.5 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Evergraf 0.5 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Evergraf 0.5 mg. Evergraf 0.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Evergraf 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Evergraf 0.5 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Evergraf 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Evergraf 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Evergraf 0.5 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Evergraf 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Evergraf 0.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Evergraf 0.5 mg.